Mustang Bio (MBIO) Other Non Operating Income (2023)
Mustang Bio (MBIO) posted quarterly Other Non Operating Income of -$2.8 million for Q2 2023.
Mustang Bio (MBIO) Other Non Operating Income (2023) Analysis & Trends
Mustang Bio (MBIO) has reported Other Non Operating Income for 1 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Non Operating Income changed N/A year-over-year to -$2.8 million; the TTM figure through Sep 2024 stood at -$2.8 million (changed N/A YoY), while the FY2023 annual figure was -$2.8 million, changed N/A from the prior year.
- Other Non Operating Income was little changed at -$2.8 million in Q2 2023 per MBIO's latest filing.
- Across five years, Other Non Operating Income topped out at -$2.8 million in Q2 2023 and bottomed at -$2.8 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2.80 Mn |